Healthcare


 3 Healthcare Stocks Good To Look At - API, SIG, HLS

3 Healthcare Stocks Good To Look At - API, SIG, HLS

July 20, 2019 04:02 PM AEST| By Team Kalkine Media

According to the World Health Organisation, about $6.5 trillion is spent on the healthcare every year globally. With the global demand for healthcare products and services growing significantly, investment in the healthcare sector seems to be a good...

 Australian Biopharma Player, Immuron Reports 29% Record Revenue Growth for FY19

Australian Biopharma Player, Immuron Reports 29% Record Revenue Growth for FY19

July 19, 2019 10:10 PM AEST| By Team Kalkine Media

Australian biopharmaceutical company,Immuron Limited (ASX: IMC), headquartered in Carlton, is engaged in developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases...

 A Look At Four ASX-Listed Biotech Stocks With Significant YTD Returns – PNV, TLX, BOT, CUV

A Look At Four ASX-Listed Biotech Stocks With Significant YTD Returns – PNV, TLX, BOT, CUV

July 17, 2019 08:26 PM AEST| By Team Kalkine Media

The biotechnology sector is one of those sectors that presents an incredible opportunity for huge returns to investors. This is because the business of curing diseases can be lucrative, and any company with a small market capitalisation can be worth...

 Recent Updates On 4 Healthcare Stocks- 1AD, IMC, NEU & SCU

Recent Updates On 4 Healthcare Stocks- 1AD, IMC, NEU & SCU

July 17, 2019 05:46 PM AEST| By Team Kalkine Media

Healthcare Healthcare sector comprises of the companies that offer medical services, producing medical equipment or medicines. These companies also give medical insurance to the patients. In Australia, the funding of healthcare is taken care of by...

 Prescient Therapeutics’ Cancer Trials Backed By A Robust Product Portfolio

Prescient Therapeutics’ Cancer Trials Backed By A Robust Product Portfolio

July 17, 2019 04:15 PM AEST| By Team Kalkine Media

Clinical stage oncology company Prescient Therapeutics Limited (ASX: PTX) is in the process of developing a breakthrough to traditional therapies by its novel drug candidates that have shown great promise in the treatment of a range of cancers that h...

 Prescient Therapeutics starts Phase 1b clinical trial of its unique inhibitor PTX-100

Prescient Therapeutics starts Phase 1b clinical trial of its unique inhibitor PTX-100

July 16, 2019 03:56 PM AEST| By Team Kalkine Media

On 11 July 2019, Prescient Therapeutics Limited (ASX: PTX) announced the commencement of a Phase 1b trial of its second targeted anti-cancer drug PTX-100 in patients with multiple cancers. The trial would reportedly be led by one of the world?s leadi...

 Imugene Expands Immunotherapy Platform, Announces Licensing of Oncolytic Virus CF33 from City of Hope Cancer Centre

Imugene Expands Immunotherapy Platform, Announces Licensing of Oncolytic Virus CF33 from City of Hope Cancer Centre

July 16, 2019 01:13 PM AEST| By Team Kalkine Media

A biotech company headquartered in Australia, Imugene Limited (ASX: IMU) develops new and novel immunotherapies that seek to harness the cancer patients? immune system against tumors. The company?s unique platform technologies seeks to potentially ac...

 4 Healthcare Stocks With Recent Updates - RNO, TLX, BOT, PAA

4 Healthcare Stocks With Recent Updates - RNO, TLX, BOT, PAA

July 15, 2019 10:51 PM AEST| By Team Kalkine Media

The below-mentioned healthcare stocks have provided significant returns in the last six months and have come up with major updates today (i.e. 15th July 2019).? Let?s take a look at these updates. Rhinomed Limited (ASX: RNO) A Melbourne-based tech...

 Noxopharm’s clinical programs aiming to unveil a potential blockbuster drug in the cancer treatment spectrum

Noxopharm’s clinical programs aiming to unveil a potential blockbuster drug in the cancer treatment spectrum

July 15, 2019 02:20 PM AEST| By Team Kalkine Media

Clinical stage drug development company, Noxopharm Limited (ASX: NOX) aims to bring hope to cancer patients who have reached the end of their treatment journey and have no standard treatment options remaining, except palliative therapy for pain-relie...

 Three Australian Healthcare Players- API, SIG, HLS

Three Australian Healthcare Players- API, SIG, HLS

July 15, 2019 01:32 PM AEST| By Team Kalkine Media

?Health is wealth? stands true when it comes to the overall growth and development of the economy. As the emphasis on health is strong and significant in every society, with evolving time, the health care sector has risen to become a booming business...

 2 Healthcare Stocks With Recent Updates: MVF, MXC

2 Healthcare Stocks With Recent Updates: MVF, MXC

July 11, 2019 10:25 PM AEST| By Team Kalkine Media

The below-mentioned healthcare stocks have announced significant updates today (i.e., 11th July 2019). Let?s take a look at these stocks and their updates. Monash IVF Group (ASX: MVF) A leading provider of assisted reproductive services and specia...

 What Made These Health Care Stocks- NXS, IXC, PME Popular Among Investors?

What Made These Health Care Stocks- NXS, IXC, PME Popular Among Investors?

July 11, 2019 05:55 PM AEST| By Team Kalkine Media

In the last one month, the shares of NXS and PME have generated a return of 26.81% and 27.58%, respectively. By the closure of the trading session, on 11 July 2019, the price of NXS? shares were at A$4.20, with a growth of 1.259% from its last close...

 Needle on Healthcare Stocks – IMM, UCM, M7T

Needle on Healthcare Stocks – IMM, UCM, M7T

July 10, 2019 05:50 PM AEST| By Team Kalkine Media

The benchmark index S&P/ASX 200 is trading at 6,665.7 on 10 July 2019 (AEST 01:58 PM), up 0.45%, while the S&P/ASX 200 Health Care Index is up 0.4% to 34,275.1. Let us discuss three healthcare stocks listed on ASX, along with their recent upd...

 A Glance At Top 20 Cannabis Companies In Australia

A Glance At Top 20 Cannabis Companies In Australia

July 08, 2019 10:50 PM AEST| By Team Kalkine Media

With the legalisation of medical cannabis in many countries like Canada, the global medical cannabis industry has boomed quite a bit in recent times. Let?s take a quick look at 20 cannabis companies trading on ASX. Cann Group Limited (ASX: CAN) Au...

 Imugene Presents New HER-Vaxx Data At ESMO World Congress On Gastrointestinal Cancer

Imugene Presents New HER-Vaxx Data At ESMO World Congress On Gastrointestinal Cancer

July 08, 2019 08:37 PM AEST| By Team Kalkine Media

A biotechnology company listed on the Australian Stock Exchange (ASX), Imugene Limited (ASX: IMU) develops cancer immunotherapies targeting B-cell peptide vaccines. The immunotherapies developed by the company seek to activate the cancer patients? im...

 Latest Updates on Four Healthcare Stocks - SOM, ADO, VHT, IMU

Latest Updates on Four Healthcare Stocks - SOM, ADO, VHT, IMU

July 08, 2019 06:28 PM AEST| By Team Kalkine Media

Health and medical industry of Australia focuses on the world?s leading technology, advanced research, development and innovation. Over the years, the industry has registered strong growth in terms of both size and reputation. Let us discuss four co...

 A Glance At Medical Device Company, Osprey Medical, Inc.

A Glance At Medical Device Company, Osprey Medical, Inc.

July 05, 2019 06:09 PM AEST| By Team Kalkine Media

Headquartered in the United States, Osprey Medical, Inc. (ASX: OSP) is engaged in protecting patients from the adverse effects of X-ray dye used commonly while performing the angiographic imaging procedures. Osprey aims to make heart imaging procedur...

 Potential ground-breaking outcomes for Veyonda<sup>®</sup> at SNMMI 2019 Conference

Potential ground-breaking outcomes for Veyonda® at SNMMI 2019 Conference

July 05, 2019 12:46 PM AEST| By Team Kalkine Media

In the world of cancer, one?billion-dollar molecule that has been making?a?big noise for its potential to extend life in men with the late-stage prostate cancer,?concerns an experimental radioactive drug called Lutetium-177 (177Lu) labelled PSMA-617...

 Prescient Therapeutics’ drug candidates addressing the mutations causing cancer

Prescient Therapeutics’ drug candidates addressing the mutations causing cancer

July 02, 2019 02:54 PM AEST| By Team Kalkine Media

Clinical-Stage oncology company, Prescient Therapeutics Limited (ASX: PTX) bases the foundation of its business model on the ground-breaking technology that addresses the mutations causing cancer. The company?s mainstream operations are focused on th...

 A look at Manufacturing, Healthcare and Marketing stocks- TTT, BDA, PPL

A look at Manufacturing, Healthcare and Marketing stocks- TTT, BDA, PPL

July 01, 2019 02:32 PM AEST| By Team Kalkine Media

Titomic Limited The digital manufacturing solutions company, Titomic (ASX: TTT) is headquartered in Melbourne, Australia, and engaged in the additive manufacturing sector. Its proprietary Titomic Kinetic Fusion? (TKF) technology is designed to perfo...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.